Skip to content
★ Sign in to follow
Rossari Biotech Limited logo

Rossari Biotech Limited Stock: price and insider trades · India

IN·Mcap ₹24.2BHealth Care

Rossari Biotech Limited: what insiders have been doing

This page follows insider dealings at Rossari Biotech Limited as filed with SEBI (PIT + SAST), a company from the Health Care sector. From 24 October 2025 to 24 October 2026, the disclosure feed for Rossari Biotech Limited logged 1 filing by 1 insider.

Only sales appear on the open market, 1 sale in all, filed by 1 insider. The amount is not disclosed for 1 filing.

Across the 1,891 companies tracked on its exchange, the median is 4 filings; at 1 filing, this issuer sits below that mark. Our records for Rossari Biotech Limited go back to 2021, with no purchases and 3 sales on the open market in total.

Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.

Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.

Insider Decl.
61
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€33,583
3 ops. · all time

Who traded when

BuySale
SBI Mutual Fund1 sale

Analyst consensus: bullish or bearish?

Analysts rate Rossari Biotech Limited Strong Buy (bullish), based on 4 analysts. Average price target: ₹610.50.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 12,377 of 26,912 companies
53.6
score / 100
Value
50
Quality
58
FCF yld-8.2%
Earn yld6.2%
EV/EBITDA9.2x
ROE11%
Gross mgn30%
Net mgn6.2%
Debt/EBITDA1.4x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

₹437.50
Analyst consensus
4 analysts
Strong buy
₹570.00Target ₹610.50(+40%)₹637.00
Income statement
Revenue₹23.9B
Gross profit₹7.1B30% margin
EBITDA₹3.1B13% margin
Net income₹1.5B5.7% margin
Valuation
PER (trailing)16.1x
PER (forward)13.0x
P/Book1.7x
Beta0.58
Balance sheet & cash
Market cap₹24.2B
Total debt₹4.4B
Free Cash Flow-₹2B
Debt / Equity28%
Profitability & ownership
ROE11.5%
ROA5.6%
% insiders68.1%
% institutions14.7%
Last declaration on 26 May 2026
Declarations61 total
  • ▼
    Related company / holdingExecutives
    0SEBI
    157,000 shares-MarketSEBI:fede3906607be1623b9dd6424d482b601d7a4d2d
  • ●
    3B INR25SEBI
    5,000,000 shares@ ₹617.25100.0% of flowEquity SharesSEBI:80f65032edb6ceccadfe97ef639131742516e8eb
  • ●
    Executives
    5B INR10SEBI
    8,800,000 shares@ ₹617.25100.0% of flowEquity SharesSEBI:13b6824e24d293c8733f08fcacc3962de6ab6cd0
  • ●
    Executives
    926M INR25SEBI
    1,500,000 shares@ ₹617.25100.0% of flowEquity SharesSEBI:4e6eceff5c1ae32f952c800fc8edd5e03bd5c1d1
  • ●
    Executives
    1B INR25SEBI
    2,300,000 shares@ ₹617.25100.0% of flowEquity SharesSEBI:31661035bbd8ee6d77e5457680a747d6976cb4ba
  • ●
    Executives
    136,630 INR2SEBI
    100 shares@ ₹1,366.300.0006% mcap1.3% of flowEquity SharesSEBI:ca673e86f42ed75f2485086b8eb963c51f3fcdb1
  • ●
    Executives
    819,600 INR4SEBI
    600 shares@ ₹1,366.000.0038% mcap15.9% of flowEquity SharesSEBI:f590f5e16bbabe7575f8015d9c1583cf99df5a4d
  • ●
    Executives
    688,125 INR4SEBI
    500 shares@ ₹1,376.250.0031% mcap15.6% of flowEquity SharesSEBI:aa9a07d8e523ba149f64e83935a07dd7f9c02089
  • ●
    Executives
    2M INR4SEBI
    1,300 shares@ ₹1,350.050.0081% mcap15.6% of flowEquity SharesSEBI:bf395dce041eca2665c9e7b308203e9cb549bed6
  • ●
    Executives
    4M INR3SEBI
    3,000 shares@ ₹1,351.8450.019% mcap14.8% of flowEquity SharesSEBI:a149cd4418544a297de31aafcced124e2f062e0c
  • ●
    Executives
    1M INR2SEBI
    1,000 shares@ ₹1,356.6880.0062% mcap5.0% of flowEquity SharesSEBI:1faa9b99d7ead838c513de5bc134df251c248a0c
  • ●
    Executives
    546,520 INR3SEBI
    400 shares@ ₹1,366.300.0025% mcap9.8% of flowEquity SharesSEBI:977e3441a347f242d77b2211b902884e0b8e71d1
  • ●
    Executives
    5M INR7SEBI
    3,600 shares@ ₹1,376.250.023% mcap54.3% of flowEquity SharesSEBI:2320afe5729a7bcfce65d5e9e9dae69dbdcabc76
  • ●
    Executives
    705,000 INR4SEBI
    500 shares@ ₹1,410.000.0032% mcap22.4% of flowEquity SharesSEBI:0bb9f833c4b2adfb735128457c262b7bbbdcf328
  • ●
    Executives
    707,500 INR3SEBI
    500 shares@ ₹1,415.000.0032% mcap9.2% of flowEquity SharesSEBI:d36ffd1b960eb4687e238fc1d0d5deaad22c30a4
  • ●
    Executives
    705,500 INR4SEBI
    500 shares@ ₹1,411.000.0032% mcap22.4% of flowEquity SharesSEBI:7ff869b1530242843c1f930954ceda8e2746ed1f
  • ●
    Executives
    4M INR5SEBI
    3,000 shares@ ₹1,375.43370.019% mcap28.8% of flowEquity SharesSEBI:3c3af26c104c89bd06e3260fa0202cea8de8607b
  • ▼
    Executives
    829,332 INR18SEBI
    600 shares@ ₹1,382.220.0038% mcap41.6% of flowEquity SharesSEBI:e726c5056a320b69c718d22c2cab508d9ee2610b
  • ●
    Executives
    4M INR6SEBI
    2,600 shares@ ₹1,432.84770.017% mcap35.6% of flowEquity SharesSEBI:a2d6ceb9e03287db721bdf18f41c9636c89cad45
  • ●
    Executives
    3M INR3SEBI
    2,000 shares@ ₹1,392.18050.013% mcap10.1% of flowEquity SharesSEBI:2ef3a7869d3a408f894104841a56c68d60cc0a2e
  • ●
    Executives
    5M INR5SEBI
    3,500 shares@ ₹1,379.84290.022% mcap32.1% of flowEquity SharesSEBI:c4059dd8ec8bad49ae7f5e7f946e5f30283757a6
  • ●
    Executives
    10M INR5SEBI
    7,000 shares@ ₹1,370.000.044% mcap32.0% of flowEquity SharesSEBI:16a98073f3c41c8b36cf78e9b0e9e225b0f2e3dd
  • ●
    Executives
    1M INR4SEBI
    750 shares@ ₹1,398.27330.0048% mcap20.3% of flowEquity SharesSEBI:c779f16324c4843ff2efff6a317293fced442727
  • ▼
    Executives
    2M INR6SEBI
    1,500 shares@ ₹1,415.000.0097% mcap37.8% of flowEquity SharesSEBI:fc4cad628f725b5d9f8e0375ce495468784f75cb
  • ●
    Executives
    11M INR6SEBI
    8,000 shares@ ₹1,391.750.051% mcap37.0% of flowEquity SharesSEBI:85615f99970421573e1b2cce8d5d92af703f63ac

25 of 61 declarations

About Rossari Biotech Limited

Rossari Biotech Limited is an Indian company that specializes in manufacturing chemical products for the textile, paint, and personal care sectors. It focuses on innovation and sustainability in its production processes.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations